News Sentiment

ADMA sentiment intelligence

ADMA Biologics Inc news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 32 Cautious news tone 57 relevant articles
Exchange NASDAQ United States
Sector Healthcare Market context
Industry Biotechnology Read-through group
Latest close 8.31 Week of 19 Jun 2026
Weighted tone 32/100

Cautious news tone

Market reaction Bad news being absorbed

Cautious headlines are being absorbed by price, which can signal underlying demand.

Primary event Regulatory and legal

81/100 classification confidence.

Company focus 50

directly relevant articles

Source quality 0

high-authority source matches

Trend context Trend inactive

+1.2% over one week, +0.8% over four weeks, trend inactive, and below fair value.

Latest direct headline Negative

ADMA Deadline Alert: Levi & Korsinsky Reminds ADMA BIOLOGICS, INC. (ADMA) Investors of Securities Class Action Deadline on August 10, 2026

Market Reaction

Bad news being absorbed

80/100 confidence

Cautious headlines are being absorbed by price, which can signal underlying demand.

Primary event Regulatory and legal 81/100 classification
One-week reaction 1.2% Price digesting
Trend fit Trend inactive 0.8% over four weeks
Fair value -34.6% Below fair value
Caution agrees with inactive trend

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 6
Neutral 21
Negative 30

Relevance

Why the article matched

Direct first
Direct company coverage 50
Industry context 7
Sector context 0

Sources

Coverage mix

Publishers
GlobeNewswire 14
Market source 10
simplywall.st 7
PR Newswire 5
ACCESS Newswire 3
Intellectia AI 3
Caledonian Record 2
DirectorsTalk Interviews 2

Event Lens

What the news is about

Classified themes
Regulatory and legal 33
Earnings 12
Market update 10
Guidance 1
Capital return 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 1-30 of 57
GlobeNewswire Direct company coverage

ADMA Deadline Alert: Levi & Korsinsky Reminds ADMA BIOLOGICS, INC. (ADMA) Investors of Securities Class Action Deadline on August 10, 2026

Levi & Korsinsky, LLP reminds investors of ADMA Biologics, Inc. (ADMA) about a securities class action lawsuit deadline on August 10, 2026. The lawsuit alleges ADMA used "channel stuffing" to falsely inflate ASCENIV revenues, turning a reported 20% growth into an estimated 3% dec

Tone
Negative 14/100
Event
Regulatory and legal
Published
22 Jun 2026 13:39
Source
GlobeNewswire
GlobeNewswire Direct company coverage

ADMA Alert: ADMA Biologics Investors may have been Misled

A securities fraud class action lawsuit has been filed against ADMA Biologics, Inc. (NASDAQ:ADMA) and its executives. This action follows a significant stock drop attributed to allegations of "channel stuffing" by Culper Research, leading to a reported 20% revenue growth in 2025

Tone
Negative 13/100
Event
Regulatory and legal
Published
22 Jun 2026 10:39
Source
GlobeNewswire
ACCESS Newswire Direct company coverage

ADMA ALERT: Securities Fraud Class Action Launched Against ADMA Biologics, Inc. – August 10, 2026 Deadline

Levi & Korsinsky, LLP has filed a securities class action lawsuit against ADMA Biologics, Inc. on behalf of investors who purchased securities between August 9, 2024, and March 25, 2026. The lawsuit alleges that ADMA Biologics engaged in an undisclosed related party transaction,

Tone
Neutral 50/100
Event
Regulatory and legal
Published
21 Jun 2026 22:39
Source
ACCESS Newswire
ACCESS Newswire Direct company coverage

Class Action Lawsuit Filed: ADMA Biologics, Inc. (ADMA) – Join by August 10, 2026 – Contact Levi & Korsinsky

Levi & Korsinsky, LLP has filed a securities class action lawsuit against ADMA Biologics, Inc. on behalf of investors who purchased securities between August 9, 2024, and March 25, 2026. The lawsuit alleges that ADMA Biologics made false statements, concealed a related party tran

Tone
Negative 8/100
Event
Regulatory and legal
Published
21 Jun 2026 20:10
Source
ACCESS Newswire
Intellectia AI Direct company coverage

Reminder for ADMA Biologics Securities Class Action

The article serves as a reminder for investors who purchased ADMA Biologics securities between August 9, 2024, and March 25, 2026, to apply as lead plaintiff in a class action lawsuit by August 10, 2026. The lawsuit alleges that ADMA Biologics made false statements, including und

Tone
Negative 25/100
Event
Regulatory and legal
Published
21 Jun 2026 13:09
Source
Intellectia AI
PR Newswire Direct company coverage

ADMA Investors Have Opportunity to Lead ADMA Biologics, Inc. Securities Fraud Lawsuit Filed by The Rosen Law Firm

The Rosen Law Firm has filed a securities class action lawsuit against ADMA Biologics, Inc., alleging securities fraud for misleading statements about undisclosed related-party transactions, channel stuffing, and inadequate internal controls. Investors who purchased ADMA securiti

Tone
Neutral 50/100
Event
Regulatory and legal
Published
21 Jun 2026 12:09
Source
PR Newswire
Market source Direct company coverage

ADMA Biologics (ADMA) Hit With Federal Securities Lawsuit Over Revenue Inflation Allegations

ADMA Biologics (NASDAQ:ADMA) is facing a federal securities lawsuit alleging revenue inflation through channel stuffing and concealed distribution relationships, following a short-seller report. This legal challenge comes despite a recent "Outperform" rating from Raymond James, w

Tone
Negative 19/100
Event
Regulatory and legal
Published
20 Jun 2026 16:34
Source
Market source
The Globe and Mail Direct company coverage

ADMA Biologics, Inc. Notice of August 10, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline

Kahn Swick & Foti, LLC (KSF) has issued a notice regarding a class action securities lawsuit against ADMA Biologics, Inc. Investors who purchased ADMA securities between August 9, 2024, and March 25, 2026, and suffered losses, have until August 10, 2026, to apply for lead plainti

Tone
Negative 13/100
Event
Regulatory and legal
Published
20 Jun 2026 03:40
Source
The Globe and Mail
StreetInsider Direct company coverage

ADMA Biologics, Inc. Notice of August 10, 2026 Application Deadline for Class Action Lawsuit

Kahn Swick & Foti, LLC (KSF) has issued a notice for a class action lawsuit against ADMA Biologics, Inc., informing investors of an August 10, 2026, application deadline to serve as lead plaintiff. The lawsuit alleges that ADMA Biologics and its executives failed to disclose mate

Tone
Negative 13/100
Event
Regulatory and legal
Published
19 Jun 2026 19:38
Source
StreetInsider
GlobeNewswire Direct company coverage

ROSEN, THE FIRST FILING FIRM, Encourages ADMA Biologics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm – ADMA

The Rosen Law Firm is encouraging investors of ADMA Biologics, Inc. (NASDAQ: ADMA) who purchased securities between August 9, 2024, and March 25, 2026, to secure legal counsel before the August 10, 2026 lead plaintiff deadline in a securities class action. The lawsuit alleges tha

Tone
Negative 29/100
Event
Regulatory and legal
Published
19 Jun 2026 17:38
Source
GlobeNewswire
Stock Traders Daily Direct company coverage

How Adma Biologics Inc (ADMA) Affects Rotational Strategy Timing

This article analyzes Adma Biologics Inc (ADMA) using AI models to provide insights for rotational strategy timing. It identifies strong near and mid-term sentiment but a weak long-term outlook, with a notable 159.0:1 risk-reward setup. The report details specific institutional t

Tone
Positive 72/100
Event
Guidance
Published
19 Jun 2026 14:56
Source
Stock Traders Daily
Caledonian Record Direct company coverage

ADMA Shareholder Alert: August 10, 2026 Lead Plaintiff Deadline in ADMA Biologics, Inc. ...

The Gross Law Firm has issued a shareholder alert for ADMA Biologics, Inc. (NASDAQ: ADMA) due to alleged materially false and/or misleading statements made during the period of August 7, 2026, to March 25, 2026. Shareholders who purchased ADMA shares during this time are encourag

Tone
Negative 15/100
Event
Market update
Published
19 Jun 2026 14:16
Source
Caledonian Record
GlobeNewswire Direct company coverage

ADMA INVESTOR NOTICE: Robbins Geller Rudman & Dowd LLP

Robbins Geller Rudman & Dowd LLP has announced a class action lawsuit against ADMA Biologics, Inc. (NASDAQ: ADMA) for alleged violations of the Securities Exchange Act of 1934. Investors who purchased ADMA securities between August 9, 2024, and March 25, 2026, and suffered substa

Tone
Negative 19/100
Event
Regulatory and legal
Published
19 Jun 2026 14:15
Source
GlobeNewswire
GlobeNewswire Direct company coverage

ADMA Investors Have Opportunity to Lead ADMA Biologics, Inc. Securities Fraud Lawsuit with the Schall Law Firm

The Schall Law Firm is reminding investors of a class action lawsuit filed against ADMA Biologics, Inc. for alleged securities fraud. The lawsuit claims that ADMA made false and misleading statements, failed to disclose a related party transaction, used channel stuffing, and lack

Tone
Negative 19/100
Event
Regulatory and legal
Published
19 Jun 2026 14:10
Source
GlobeNewswire
GlobeNewswire Direct company coverage

Investor Rights Alert: ADMA Biologics (ADMA) Faces Securities Fraud Class Action after Channel Stuffing Allegations Cause 29% Stock Drop – Investors Notified to Contact BFA Law

A class action lawsuit has been filed against ADMA Biologics, Inc. (NASDAQ:ADMA) and its executives for securities fraud. This action follows a significant stock drop attributed to allegations by Culper Research of channel stuffing to inflate reported revenue growth for 2025. Inv

Tone
Negative 10/100
Event
Regulatory and legal
Published
19 Jun 2026 10:10
Source
GlobeNewswire
Insider Monkey Direct company coverage

5 Stocks Under $20 That Will Explode

The article discusses ADMA Biologics, Inc. (NASDAQ: ADMA) as one of five stocks under $20 with high upside potential, despite facing a federal securities lawsuit alleging channel stuffing and misleading statements. Raymond James issued an "Outperform" rating and a $21 price targe

Tone
Negative 38/100
Event
Regulatory and legal
Published
19 Jun 2026 00:12
Source
Insider Monkey
Intellectia AI Direct company coverage

Investors Alert: Class Action Lawsuits Against ADMA, ERAS, NNOX

Class action lawsuits have been filed against ADMA Biologics, Erasca, Inc., and Nano-X Imaging Ltd. for allegedly making false or misleading statements that led to investor losses. Holzer & Holzer, LLC is representing shareholders in these cases, with deadlines for lead plaintiff

Tone
Negative 15/100
Event
Regulatory and legal
Published
18 Jun 2026 21:12
Source
Intellectia AI
PR Newswire Direct company coverage

ADMA Biologics, Inc. (ADMA) Class Action Lawsuit: Investors Face August 10, 2026, Deadline

Kessler Topaz Meltzer & Check, LLP has announced a securities fraud class action lawsuit against ADMA Biologics, Inc. (ADMA). The lawsuit alleges material misstatements and omissions regarding the company's revenues and internal controls, including undisclosed related-party trans

Tone
Negative 18/100
Event
Regulatory and legal
Published
18 Jun 2026 18:12
Source
PR Newswire
GlobeNewswire Direct company coverage

Deadline Alert: ADMA Biologics, Inc. (ADMA) Shareholders

Glancy Prongay Wolke & Rotter LLP has issued a deadline alert for investors who lost money in ADMA Biologics, Inc. (ADMA) securities, urging them to contact the firm regarding a securities fraud lawsuit. The class action alleges that ADMA made materially false and misleading stat

Tone
Negative 14/100
Event
Regulatory and legal
Published
18 Jun 2026 16:12
Source
GlobeNewswire
GlobeNewswire Direct company coverage

ADMA Biologics Shareholder Alert: ClaimsFiler Reminds

ClaimsFiler is alerting investors with significant losses in ADMA Biologics, Inc. (NasdaqGM: ADMA) to a lead plaintiff deadline of August 10, 2026, in a securities class action lawsuit. The lawsuit alleges that ADMA and its executives made false and misleading statements, includi

Tone
Negative 9/100
Event
Regulatory and legal
Published
18 Jun 2026 15:12
Source
GlobeNewswire
PR Newswire Direct company coverage

ADMA Shareholder Alert: ADMA BIOLOGICS, INC. Securities Class Action Lawsuit - Investors Should Contact SueWallSt

SueWallSt has issued a shareholder alert regarding a securities class action lawsuit against ADMA Biologics, Inc. (NASDAQ: ADMA). The lawsuit alleges the company made misleading statements about its revenue recognition, internal controls, and related party transactions, specifica

Tone
Negative 19/100
Event
Regulatory and legal
Published
18 Jun 2026 14:12
Source
PR Newswire
PR Newswire Direct company coverage

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in ADMA Biologics, Inc. of Class Action Lawsuit and Upcoming Deadlines - ADMA

Pomerantz LLP has filed a class action lawsuit against ADMA Biologics, Inc. (NASDAQ: ADMA) on behalf of investors who incurred losses. The lawsuit alleges securities fraud following a Culper Research report claiming "channel stuffing" and an undisclosed related party distributor

Tone
Negative 20/100
Event
Regulatory and legal
Published
18 Jun 2026 14:00
Source
PR Newswire
TMX Newsfile Direct company coverage

Grabar Law Office Investigates ADMA Biologics, Inc. (ADMA) on Behalf of Long-Term Shareholders

Grabar Law Office is investigating ADMA Biologics, Inc. (ADMA) regarding potential breaches of fiduciary duties by its officers and directors. The investigation focuses on allegations of inadequate internal controls, inflated revenue through channel-stuffing, undisclosed related-

Tone
Negative 18/100
Event
Regulatory and legal
Published
18 Jun 2026 12:40
Source
TMX Newsfile
GlobeNewswire Direct company coverage

ADMA LAWSUIT ALERT: Bragar Eagel & Squire, P.C. Announces

Bragar Eagel & Squire, P.C. announced a class action lawsuit against ADMA Biologics, Inc. (NASDAQ:ADMA) for alleged false and misleading statements, including an undisclosed related party transaction and channel stuffing. The lawsuit covers investors who purchased ADMA securities

Tone
Negative 13/100
Event
Regulatory and legal
Published
17 Jun 2026 22:39
Source
GlobeNewswire
ACCESS Newswire Direct company coverage

Class Action Alert: Levi & Korsinsky Reminds ADMA Biologics, Inc. (ADMA) Investors of August 10, 2026 Deadline

Levi & Korsinsky, LLP has filed a securities class action lawsuit against ADMA Biologics, Inc. (NASDAQ:ADMA) on behalf of investors who suffered losses due to alleged securities fraud between August 9, 2024, and March 25, 2026. The lawsuit claims ADMA Biologics engaged in an undi

Tone
Negative 19/100
Event
Regulatory and legal
Published
17 Jun 2026 21:39
Source
ACCESS Newswire
PR Newswire Direct company coverage

ADMA DEADLINE: Levi & Korsinsky Reminds ADMA BIOLOGICS, INC. Investors of Upcoming Securities Class Action Deadline

Levi & Korsinsky, LLP reminds investors of ADMA Biologics, Inc. (NASDAQ: ADMA) about a looming securities class action deadline of August 10, 2026. The lawsuit alleges that ADMA falsely certified effective internal controls while engaging in a channel stuffing scheme and conceali

Tone
Negative 14/100
Event
Regulatory and legal
Published
17 Jun 2026 14:39
Source
PR Newswire